Lwitiko Sikana

Lwitiko Sikana

Auto-generated profile, based on publicly available information

Lwitiko Sikana

Affiliation Environmental Health and Ecological Sciences, Ifakara Health Institute, Dar es Salaam, Tanzania

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 March 2021 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
LSLwitiko Sikana
Lwitiko Sikana
TLTiziana Lembo
Tiziana Lembo
KHKatie Hampson
Katie Hampson
KLKennedy Lushasi
Kennedy Lushasi
SMSally Mtenga
Sally Mtenga
KKKatharina Kreppel
Katharina Kreppel
Interventions tackling zoonoses require an understanding of healthcare patterns related to both human and animal hosts. The control of dog-mediated rabies is a good example. Despite the availability of effective control measures, 59,000 people die of rabies every year worldwide. In Tanzania, children are most at risk, contributing ~40% of deaths. Mass dog vaccination can break the transmission cycle, but reaching the recommended 70% coverage is challenging where vaccination depends on willingness to vaccinate dogs. Awareness campaigns in communities often target children, but do not consider other key individuals in the prevention chain. Understanding factors related to dog ownership and household-level responsibility for dog vaccination and child health is critical to the design of vaccination strategies. We investigated who makes household decisions about dogs and on health care for children in rural Tanzania. In the Kilosa district, in-depth interviews with 10 key informants were conducted to inform analysis of data from a household survey of 799 households and a survey on Knowledge Attitudes and Practices of 417 households. The in-depth interviews were analysed using framework analysis. Descriptive analysis showed responsibilities for household decisions on dogs’ and children’s health. Multivariate analysis determined factors associated with the probability of dogs being owned and the number of dogs owned, as well as factors associated with the responsibility for child health. Dog ownership varied considerably between villages and even households. The number of dogs per household was associated with the size of a household and the presence of livestock. Children are not directly involved in the decision to vaccinate a dog, which is largely made by the father, while responsibility for seeking health care if a child is bitten lies with the mother. These novel results are relevant for the design and implementation of rabies interventions. Specifically, awareness campaigns should focus on decision-makers in households to improve rabies prevention practices and on the understanding of processes critical to the control of zoonoses more broadly.

14 May 2026 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
KLKennedy Lushasi
Kennedy Lushasi
EREleanor M. Rees
Eleanor M. Rees
CBCamille Barker
Camille Barker
NCNai Rui Chng
Nai Rui Chng
AHAlly Halfan
Ally Halfan
KHKatie Hampson
Katie Hampson
Rabies remains a preventable yet fatal disease that continues to claim lives in low- and middle-income countries due to barriers in accessing post-exposure prophylaxis (PEP). With Gavi, the Vaccine Alliance, now supporting PEP provision in rabies-endemic countries, understanding access barriers is critical. We used mixed-methods to synthesise quantitative data on bite patients (>10,000) captured through an Integrated Bite Case Management platform across four regions of Tanzania, with qualitative data from hotline calls and peer-support chat established among health and veterinary workers from 2018 to 2024. We applied an expanded healthcare access framework comprising six dimensions: availability, accessibility, affordability, accommodation, acceptability, and appropriateness to guide our analyses and assess barriers and facilitators to PEP delivery and uptake in these regions. We identified interconnected barriers to PEP access including recurrent vaccine stockouts (up to 9.2% regionally); long travel distances that were greater for rural patients (on average: 34 vs 13 km for urban patients) who represented the majority at risk; and unaffordable direct and indirect costs leading bite victims to either not start or abandon PEP, incur risky delays or default to traditional remedies. Incorrect bite patient management, including misuse of biologicals sold at unregulated private pharmacies led to preventable deaths, while insufficient vaccination supplies and inadequate service hours, increased risks and costs to patients. Despite these gaps, peer-support mechanisms improved patient management and real-time problem-solving. PEP delivery in Tanzania is undermined by systemic barriers across all access dimensions. Addressing these requires decentralizing vaccine delivery to prioritized accessible facilities, ensuring reliable stock and supplies for intradermal administration, reducing patient costs, strengthening health worker capacity through training and support, and regulating private providers. Lessons from Tanzania highlight the need for context-sensitive, equity-focused strategies to maximize the impact of Gavi’s investment and accelerate progress toward Zero by 30.

29 November 2022 in medRxiv
Verified
Preprint
Open access
PDF file
KLKennedy Lushasi
Kennedy Lushasi
KBKirstyn Brunker
Kirstyn Brunker
MRMalavika Rajeev
Malavika Rajeev
EFElaine A Ferguson
Elaine A Ferguson
GJGurdeep Jaswant
Gurdeep Jaswant
KHKatie Hampson
Katie Hampson
Background Dog-mediated rabies is endemic across Africa causing thousands of human deaths annually. A One Health approach to rabies is advocated, comprising emergency post-exposure vaccination of bite victims and mass dog vaccination to break the transmission cycle. However, the impacts and cost-effectiveness of these components are difficult to disentangle. Methods We combined contact tracing with whole-genome sequencing to track rabies transmission in the animal reservoir and spillover risk to humans from 2010-2020, investigating how the components of a One Health approach reduced the disease burden and eliminated rabies from Pemba island, Tanzania. With the resulting high-resolution spatiotemporal and genomic data we inferred transmission chains, estimated case detection and quantified the public health burden to evaluate these interventions. Results We resolved five transmission chains co-circulating on Pemba from 2010 that were all eliminated by May 2014. During this period, rabid dogs, human rabies exposures and deaths all progressively declined following initiation and improved implementation of annual islandwide dog vaccination. We identified two introductions to Pemba in late 2016 that seeded re-emergence after dog vaccination had lapsed. The ensuing outbreak was eliminated in October 2018 through reinstated islandwide dog vaccination. While post-exposure vaccines were highly cost-effective ($405 per death averted), their accessibility was limited and only dog vaccination interrupted transmission. A combined One Health approach rapidly eliminated rabies, was highly cost-effective ($1865 per death averted) and saved 20-120 families from rabid dog bites annually. Conclusions A One Health approach underpinned by dog vaccination is an efficient, cost-effective, equitable and feasible approach to rabies elimination, but needs scaling up across connected populations to sustain the benefits of elimination, as seen on Pemba, and for similar progress to be achieved elsewhere. Funding Wellcome [207569/Z/17/Z, 095787/Z/11/Z, 103270/Z/13/Z], the UBS Optimus Foundation, and the DELTAS Africa Initiative [Afrique One-ASPIRE/DEL-15-008] comprising a donor consortium of the African Academy of Sciences (AAS), Alliance for Accelerating Excellence in Science in Africa (AESA), the New Partnership for Africa’s Development Planning and Coordinating (NEPAD) Agency, Wellcome [107753/A/15/Z] and the UK government. The rabies elimination demonstration project from 2010-2015 was supported by the Bill & Melinda Gates Foundation (OPP49679) and whole-genome sequencing was partially supported at APHA by Defra grant SE0421.

4 September 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
RDRowan Durrant
Rowan Durrant
CCChristina A. Cobbold
Christina A. Cobbold
KBKirstyn Brunker
Kirstyn Brunker
KCKathryn Campbell
Kathryn Campbell
JDJonathan Dushoff
Jonathan Dushoff
KHKatie Hampson
Katie Hampson
The molecular clock hypothesis assumes that mutations accumulate on an organism’s genome at a constant rate over time, but this assumption does not always hold true. While modelling approaches exist to accommodate deviations from a strict molecular clock, assumptions about rate variation may not fully represent the underlying evolutionary processes. There is considerable variability in rabies virus (RABV) incubation periods, ranging from days to over a year, during which viral replication may be reduced. This prompts the question of whether modelling RABV on a per infection generation basis might be more appropriate. We investigate how variable incubation periods affect root-to-tip divergence under per-unit time and per-generation models of mutation. Additionally, we assess how well these models represent root-to-tip divergence in time-stamped RABV sequences. We find that at low substitution rates (<1 substitution per genome per generation) divergence patterns between these models are difficult to distinguish, while above this threshold differences become apparent across a range of sampling rates. Using a Tanzanian RABV dataset, we calculate the mean substitution rate to be 0.17 substitutions per genome per generation. At RABV’s substitution rate, the per-generation substitution model is unlikely to represent rabies evolution substantially differently than the molecular clock model when examining contemporary outbreaks; over enough generations for any divergence to accumulate, extreme incubation periods average out. However, measuring substitution rates per-generation holds potential in applications such as inferring transmission trees and predicting lineage emergence. Author Summary: Rabies is a neglected disease that kills around 60,000 people each year. After entering the body, the incubation period of the virus is usually less than one month, but can sometimes span months to years. While we normally assume a virus accumulates mutations at a constant rate, it is possible that rabies’ occasional long incubation periods mean that mutations accumulate at varying rates if the virus replicates (and thus mutates) more slowly during the incubation period. We compared how the rabies virus evolves over time using two simulation models where mutations either occur per unit time or per infection generation. We also calculated the mean substitution rate per infection generation, which can be useful for inferring linkage between related rabies cases. We found that at realistic substitution rates for the rabies virus, we could not distinguish between the two models. Our calculations show that in most generations no mutations are expected to occur. Thus, over a time period long enough to observe genetic divergence, occasional long incubation periods would be “cancelled out” by shorter than average incubation periods, meaning that the two models are almost equivalent. However our work suggests that modelling substitution rates per generation may be useful for epidemiological inference.

1 January 2022 in SSRN Electronic Journal
Verified
Preprint
Open access
PDF file
KLKennedy Lushasi
Kennedy Lushasi
KBKirstyn Brunker
Kirstyn Brunker
MRMalavika Rajeev
Malavika Rajeev
EFElaine A. Ferguson
Elaine A. Ferguson
GJGurdeep Jaswant
Gurdeep Jaswant
KHKatie Hampson
Katie Hampson
Background: Dog-mediated rabies is endemic across Africa causing thousands of deaths annually. We investigated how components of a One Health approach, post-exposure vaccination of bite victims and dog vaccination, reduced the disease burden and eliminated rabies from Pemba island, Tanzania. Methods: From 2010-2020 we conducted islandwide contact tracing of animal rabies cases, human rabies exposures and deaths and whole-genome sequencing of sampled viruses. With the resulting data we inferred transmission chains, estimated case detection and quantified the public health burden, evaluating these interventions’ impacts and cost-effectiveness. Findings: We resolved five transmission chains circulating on Pemba from 2010 that were all eliminated by May 2014. During this period, rabid dogs, human exposures and deaths all progressively declined following initiation and improved implementation of annual islandwide dog vaccination. In late 2016 we identified two further introductions to Pemba that seeded re-emergence. The ensuing outbreak was eliminated in October 2018 through reinstated islandwide dog vaccination. Post-exposure vaccines were highly cost-effective ($405 per death averted) but accessibility was limited. Only dog vaccination interrupted transmission. A combined One Health approach on Pemba rapidly eliminated rabies, was highly cost-effective ($1865 per death averted) and saved 20-120 families from rabid dog bites annually. Interpretation: A One Health approach underpinned by dog vaccination is a cost-effective, equitable and feasible approach to rabies elimination, but needs scaling up across connected populations to sustain the benefits of elimination, as seen on Pemba, and for similar progress to be achieved elsewhere. Funding: Wellcome, UBS Optimus Foundation, Bill & Melinda Gates Foundation Funding Information: This work was funded by Wellcome [207569/Z/17/Z, 095787/Z/11/Z, 103270/Z/13/Z], the UBS Optimus Foundation, and the DELTAS Africa Initiative [Afrique One-ASPIRE/DEL-15- 008] comprising a donor consortium of the African Academy of Sciences (AAS), Alliance for Accelerating Excellence in Science in Africa (AESA), the New Partnership for Africa’s Development Planning and Coordinating (NEPAD) Agency, Wellcome [107753/A/15/Z] and the UK government. The rabies elimination demonstration project from 2010-2015 was supported by the Bill & Melinda Gates Foundation (OPP49679) and whole genome sequencing was partially supported at APHA by Defra grant SE0421. Declaration of Interests: The authors have no competing interests. Ethics Approval Statement: The study was approved by the Zanzibar Medical Research and Ethics Committee (ZAMREC/0001/JULY/014), the Medical Research Coordinating Committee of the National Institute for Medical Research of Tanzania (NIMR/HQ/R.8a/vol.IX/2788), the Ministry of Regional Administration and Local Government (AB.81/288/01), and Ifakara Health Institute Institutional Review Board (IHI/IRB/No:22-2014).

21 November 2025 in medRxiv
Verified
Preprint
Open access
PDF file
KLKennedy Lushasi
Kennedy Lushasi
EREleanor M Rees
Eleanor M Rees
CBCamille Baker
Camille Baker
NCNai Rui Chng
Nai Rui Chng
AHAlly Halfan
Ally Halfan
KHKatie Hampson
Katie Hampson
Introduction: Rabies remains a preventable yet fatal disease that continues to claim lives in low- and middle-income countries due to barriers in accessing post-exposure prophylaxis (PEP). With Gavi, the Vaccine Alliance, now supporting PEP provision in rabies-endemic countries, understanding access barriers is critical. Methods: We used mixed-methods to synthesise quantitative data on bite patients (>10,000) captured through an Integrated Bite Case Management platform across four regions of Tanzania, with qualitative data from hotline calls and peer-support chat established among health and veterinary workers (>3000) from 2018 to 2024. We applied an expanded healthcare access framework comprising six dimensions: availability, accessibility, affordability, accommodation, acceptability, and appropriateness to guide our analyses and assess barriers and facilitators to PEP delivery and uptake. Results: We identified interconnected barriers to PEP access including recurrent vaccine stockouts (up to 9.2% regionally); long travel distances that were greater for rural patients (34 vs 13 km for urban on average) who represented the majority at risk; and unaffordable direct and indirect costs leading bite victims to either not start or abandon PEP, incur risky delays or default to traditional remedies. Incorrect bite patient management, including misuse of biologicals sold at unregulated private pharmacies led to preventable deaths, while insufficient vaccination supplies and inadequate service hours, increased risks and costs to patients. Despite these gaps, peer-support mechanisms improved patient management and real-time problem-solving. Conclusions: PEP delivery in Tanzania is undermined by systemic barriers across all access dimensions. Addressing these requires decentralizing vaccine delivery to prioritized accessible facilities, ensuring reliable stock and supplies for intradermal administration, reducing patient costs, strengthening health worker capacity through training and support, and regulating private providers. Lessons from Tanzania highlight the need for context-sensitive, equity-focused strategies to maximize the impact of Gavi’s investment and accelerate progress toward Zero by 30.